Vice President, Lifecycle Leader

This is a fully remote position, open to applicants in United States.

📋 Description

• Act as the executive lifecycle leader for upcoming indications, responsible for the comprehensive asset strategy encompassing clinical development, regulatory strategy, manufacturing readiness, and commercialization planning.

• Define and uphold the integrated development plan and lifecycle strategy, ensuring alignment with the Target Product Profile and long-term commercial value drivers.

• Propel strategic planning for critical development milestones, including phase transitions, pivotal trial strategies, regulatory engagements, and launch preparedness.

• Guarantee that program execution aligns with corporate strategy, timelines, regulatory obligations, and budgetary goals.

• Lead and nurture the Lifecycle Leaders organization, offering strategic guidance and mentorship to lifecycle leads throughout Kyverna’s development portfolio.

• Establish industry-leading lifecycle governance, decision-making frameworks, and cross-program coordination processes.

• Collaborate with the Executive Leadership Team to ensure portfolio prioritization and investment decisions are in alignment with corporate strategy and value creation.

• Standardize the development of lifecycle strategies, program governance, and cross-functional planning across various programs.

• Serve as a key strategic advisor to executive leadership on program strategy, portfolio risks, and lifecycle opportunities.

• Direct the preparation and presentation of program updates, strategic alternatives, and decision packages to governance committees and the Board.

• Ensure thorough risk assessment, scenario planning, and mitigation strategies are established across the program.

• Define go/no-go decision points and facilitate governance discussions regarding program investments and strategic direction.

• Represent Kyverna in interactions with key scientific, regulatory, and industry stakeholders.

• Support strategic partnerships, collaborations, and licensing discussions as appropriate.

• Engage with key opinion leaders and external experts to inform program strategies.

• Ensure coordinated execution across all functional areas, overseeing the development and implementation of key program deliverables.

⛳️ Requirements

• PhD, MD, PharmD, MBA, or an equivalent advanced degree is preferred.

• 15+ years of experience in biotechnology or pharmaceutical drug development, including substantial leadership experience in clinical-stage programs.

• Proven success in leading complex global development programs from early development to late-stage clinical trials and regulatory submissions.

• Required experience as a program or lifecycle leader for a significant therapeutic asset.

• Strong preference for experience in Neuroimmunology.

• Preferred expertise in autoimmune diseases, immunology, cell therapy, biologics, or similar therapeutic fields.

• Extensive understanding of the complete drug development value chain, including research, translational science, clinical development, regulatory affairs, manufacturing, and commercialization.

• Experience with global regulatory interactions and major submissions (IND, BLA, NDA).

• Demonstrated leadership in cross-functional matrix organizations and enterprise governance frameworks.

• Ability to interpret complex clinical and scientific data and translate insights into strategic decisions.

• Experience in leading cross-functional teams within dynamic biotechnology environments.

• Strategic thinker with an enterprise-level perspective, capable of driving portfolio-wide impact.

• Strong executive presence with the ability to influence senior leadership and Board stakeholders.

• Proven capability to lead high-performing cross-functional teams in complex and rapidly evolving environments.

• Excellent judgment and decision-making abilities in situations of uncertainty and changing scientific data.

• Outstanding communication and stakeholder management skills.

🏝️ Benefits

• This position is also eligible for bonus opportunities, benefits, and participation in the Company’s stock plan.